ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 102 filers reported holding ORIC PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $70,000 | -92.5% | 13,097 | -79.3% | 0.00% | – |
| Q4 2021 | $929,000 | -20.9% | 63,228 | +12.6% | 0.00% | -100.0% |
| Q3 2021 | $1,174,000 | +86.6% | 56,155 | +57.8% | 0.00% | – |
| Q2 2021 | $629,000 | -32.2% | 35,581 | -6.1% | 0.00% | -100.0% |
| Q1 2021 | $928,000 | -1.0% | 37,884 | +36.8% | 0.00% | 0.0% |
| Q4 2020 | $937,000 | +53.4% | 27,694 | +13.3% | 0.00% | – |
| Q3 2020 | $611,000 | -22.8% | 24,438 | +4.3% | 0.00% | -100.0% |
| Q2 2020 | $791,000 | – | 23,438 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 4,768,181 | $161,403,000 | 14.64% |
| Invus Financial Advisors, LLC | 1,007,575 | $34,106,000 | 14.26% |
| Euclidean Capital LLC | 1,400,435 | $47,405,000 | 10.04% |
| Memorial Sloan Kettering Cancer Center | 602,272 | $20,387,000 | 8.63% |
| EcoR1 Capital, LLC | 3,092,218 | $104,672,000 | 5.63% |
| Ally Bridge Group (NY) LLC | 413,061 | $13,982,000 | 2.40% |
| Asymmetry Capital Management, L.P. | 67,210 | $2,275,000 | 1.04% |
| Orbimed Advisors | 2,921,967 | $98,909,000 | 0.86% |
| Casdin Capital, LLC | 601,515 | $20,361,000 | 0.60% |
| EMERALD ADVISERS, LLC | 522,302 | $17,680,000 | 0.59% |